CP8668, a novel orally active nonsteroidal progesterone receptor modulator with tetrahydrobenzindolone skeleton

European Journal of Pharmacology

Volumn 461, Issue 1, 2003, Pages 73-78

  Tabata, Yuji ^a   Iizuka, Yumiko ^a   Shinei, Rie ^a   Kurihara, Ken Ichi ^a   Okonogi, Tsuneo ^a   Hoshiko, Shigeru ^a   Kurata, Yasushi ^a  

^a MEIJI SEIKA KAISHA LTD   (Japan)

Author keywords

CP8668; Endometrial transformation, rabbit; PF1092; Progesterone receptor modulator, nonsteroidal; T47D

Indexed keywords

7 METHOXY 6 (N PROPYLAMINOCARBONYL)OXY 4A,5,6,7 TETRAHYDRO 1,3,4A,5 TETRAMETHYLBENZ[F]INDOL 2(4H) ONE; ANDROGEN RECEPTOR; CP 8668; ESTROGEN RECEPTOR; GESTAGEN; GLUCOCORTICOID RECEPTOR; INDOLE DERIVATIVE; MEDROXYPROGESTERONE ACETATE; MIFEPRISTONE; PROGESTERONE; PROGESTERONE RECEPTOR; PROGESTERONE RECEPTOR MODULATOR; PROMEGESTONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENCY; DRUG SELECTIVITY; ENDOMETRIUM; ENZYME ASSAY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; RECEPTOR AFFINITY; TRANSCRIPTION REGULATION;

EID: 0037423075     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)02958-8     Document Type: Article

References (18)

1. Chwalisz K., Brenner R.M., Fuhrmann U.U., Hess-Stumpp H., Elger W. Antiproliferative effects of progesterone antagonists and progesterone receptor modulators on the endometrium. Steroids. 65:2000;741-751.
2. Chwalisz K., Garg R., Brenner R.M., Schubert G., Elger W. Selective progesterone receptor modulators (SPRMs). A novel therapeutic concept in endometriosis. Ann. N .Y. Acad. Sci. 955:2002;373-388.
3. Combs D.W., Reese K., Phillips A. Nonsteroidal progesterone receptor ligands. 1. 3-Aryl-1-benzoyl-1,4,5,6-tetrahydropyridazines. J. Med. Chem. 38:1995;4878-4879.
4. Editorial, 1996. This editorial covers the meeting of European Progestin Club. Moderation of meeting: Schindler, A.E. Participants: Campagnoli, C., Druckmann, R., Huber, J., Pasqualini, J.R., Schweppe, K.W., Thijssen, J.H.H., Correspondence and reprint requests: Pasqualini, J.R. Progestins: present and future. J. Steroid Biochem. Mol. Biol. 59, 357-363.
5. Elger W., Bartley J., Schneider B., Kaufmann G., Schubert G., Chwalisz K. Endocrine pharmacological characterization of progesterone antagonists and progesterone receptor modulators with respect to PR-agonistic and antagonistic activity. Steroids. 65:2000;713-723.
6. Harimaya K., Magome E., Tabata Y., Sasaki T., Tsuruoka T. Chemical conversion of PR toxin into new eremophilanolides as progesterone receptor ligands. Sci. Rep. Meiji Seika Kaisha. 36:1997;19-27.
7. Kurihara K., Tanabe K., Shinei R., Okonogi T., Ohtsuka Y., Omoto S., Yasuda S., Tatsuta K. Synthesis of (±)-PF1092A, B, and C; new nonsteroidal progesterone receptor ligands. J. Antibiot. 50:1997;360-362.
8. Kurihara K., Tanabe K., Yamamoto Y., Shinei R., Ajito K., Okonogi T. Synthesis and structure-activity relationships of new non-steroidal progesterone receptor ligands. Bioorg. Med. Chem. Lett. 9:1999;1837-1842.
9. McPhail M.K. The assay of progestin. J. Physiol. 1934;145-156.
10. Mori T., Kurata Y., Tabata Y., Niho N., Matsuda M., Zhou Y.F. Priming effects of novel nonsteroidal progesterone receptor modulators CP8816 and CP8863 on the development of adenomyosis in the mouse uterus. Life Sci. 71:2002;527-535.
11. Palmer S., Campen C.A., Allan G.F., Rybczynski P., Haynes-Johnson D., Hutchins A., Kraft P., Kiddoe M., Lai M.T., Lombardi E., Pedersen P., Hodgen G., Combs D.W. Nonsteroidal progesterone receptor ligands with unprecedented receptor selectivity. J. Steroid Biochem. Mol. Biol. 75:2002;33-42.
12. Pathirana C., Stein R.B., Berger T.S., Fenical W., Ianiro T., Mais D.E., Torres A., Goldman M.E. Nonsteroidal human progesterone receptor modulators from the marine alga Cymopolia barbata. Mol. Pharmacol. 47:1995;630-635.
13. Tabata Y., Miike N., Hatsu M., Kurata Y., Yaguchi T., Someya A., Miyadoh S., Hoshiko S., Tsuruoka T., Omoto S. PF1092A, B and C, new nonsteroidal progesterone receptor ligands produced by Penicillium oblatum: I. Taxonomy of producing strain, fermentation, isolation and biological activities. J. Antibiot. 50:1997;304-308.
14. Tabata Y., Hatsu M., Kurata Y., Miyajima K., Tani M., Sasaki T., Kodama Y., Tsuruoka T., Omoto S. PF1092A, B and C, new nonsteroidal progesterone receptor ligands produced by Penicillium oblatum: II. Physico-chemical properties and structure elucidation. J. Antibiot. 50:1997;309-313.
15. Tabata Y., Iizuka Y., Kashiwa J., Takei Masuda N., Shinei R., Kurihara K., Okonogi T., Hoshiko S., Kurata Y. Fungal metabolite, PF1092 compounds and their derivatives, are nonsteroidal and selective progesterone receptor modulators. Eur. J. Pharmacol. 430:2001;159-165.
16. Tatsuta K., Yasuda S., Kurihara K., Tanabe K., Shinei R., Okonogi T. Total synthesis of progesterone receptor ligands, (-)-PF1092A, B, and C. Tetrahedron Lett. 38:1997;1439-1442.
17. Zhang P., Terefenko E.A., Fensome A., Zhang Z., Zhu Y., Cohen J., Winneker R., Wrobel J., Yardley J. Potent nonsteroidal progesterone receptor agonists: synthesis and SAR study of 6-aryl benzoxazines. Bioorg. Med. Chem. Lett. 12:2002;787-790.
18. Zhi L., Tegley C.M., Marschke K.B., Mais D.E., Jones T.K. 5-Aryl-1,2,3,4-tetrahydrochromeno[3,4-f]quinolin-3-ones as a novel class of nonsteroidal progesterone receptor agonists: effect of A-Ring modification. J. Med. Chem. 42:1999;1466-1472.